These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7905592)

  • 1. Reversible ischaemic neurological deficit after sclerotherapy of varicose veins.
    Van der Plas JP; Lambers JC; Van Wersch JW; Koehler PJ
    Lancet; 1994 Feb; 343(8894):428. PubMed ID: 7905592
    [No Abstract]   [Full Text] [Related]  

  • 2. Ischaemic neurological deficit after sclerotherapy.
    Trenkwalder P; Lydtin H
    Lancet; 1994 Mar; 343(8900):794. PubMed ID: 7907752
    [No Abstract]   [Full Text] [Related]  

  • 3. Stroke after varicose vein foam injection sclerotherapy.
    Forlee MV; Grouden M; Moore DJ; Shanik G
    J Vasc Surg; 2006 Jan; 43(1):162-4. PubMed ID: 16414404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regarding extensive tissue necrosis following high concentration sclerotherapy for varicose veins.
    Fisher DA
    Dermatol Surg; 2000 Nov; 26(11):1082. PubMed ID: 11096404
    [No Abstract]   [Full Text] [Related]  

  • 5. Polidocanol (Varithena) for varicose veins.
    Med Lett Drugs Ther; 2015 Aug; 57(1474):111-2. PubMed ID: 26218793
    [No Abstract]   [Full Text] [Related]  

  • 6. Sclerotherapy of varicose veins with polidocanol based on the guidelines of the German Society of Phlebology.
    Rabe E; Pannier F
    Dermatol Surg; 2010 Jun; 36 Suppl 2():968-75. PubMed ID: 20590702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible neurological deficit after foam sclerotherapy.
    Hartmann K; Harms L; Simon M
    Eur J Vasc Endovasc Surg; 2009 Nov; 38(5):648-9. PubMed ID: 19683463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regarding "Stroke after varicose vein foam injection sclerotherapy".
    Eckmann DM; Kobayashi S
    J Vasc Surg; 2006 Jul; 44(1):225; author reply 225-6. PubMed ID: 16828455
    [No Abstract]   [Full Text] [Related]  

  • 9. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H
    Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regarding "Stroke after varicose vein foam injection sclerotherapy".
    Morrison N; Cavezzi A; Bergan J; Partsch H
    J Vasc Surg; 2006 Jul; 44(1):224-5; author reply 225-6. PubMed ID: 16828453
    [No Abstract]   [Full Text] [Related]  

  • 11. Complications and side-effects of foam sclerotherapy.
    Guex JJ
    Phlebology; 2009 Dec; 24(6):270-4. PubMed ID: 19952383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embolia cutis medicamentosa of the foot after sclerotherapy.
    Geukens J; Rabe E; Bieber T
    Eur J Dermatol; 1999 Mar; 9(2):132-3. PubMed ID: 10066964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localized retiform purpura after accidental intra-arterial injection of polidocanol.
    Yébenes M; Gilaberte M; Toll A; Barranco C; Pujol RM
    Acta Derm Venereol; 2005; 85(4):372-3. PubMed ID: 16191871
    [No Abstract]   [Full Text] [Related]  

  • 14. Polidocanol (aethoxysklerol) for sclerotherapy of superficial venules and telangiectasias.
    Goldman PM
    J Dermatol Surg Oncol; 1989 Feb; 15(2):204-9. PubMed ID: 2644330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial infarction after ultrasoundguided foam sclerotherapy for varicose veins--a case report and review of the literature of a rare but serious adverse event.
    Engelberger RP; Ney B; Clair M; Dabiri A; Alatri A; Mazzolai L; Kern P
    Vasa; 2016; 45(3):255-8. PubMed ID: 27129073
    [No Abstract]   [Full Text] [Related]  

  • 16. Polidocanol for endovenous microfoam sclerosant therapy.
    Eckmann DM
    Expert Opin Investig Drugs; 2009 Dec; 18(12):1919-27. PubMed ID: 19912070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review.
    Willenberg T; Smith PC; Shepherd A; Davies AH
    Phlebology; 2013 Apr; 28(3):123-31. PubMed ID: 23761921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sclerotherapy in an undetected pregnancy - a catastrophe?
    Reich-Schupke S; Leiste A; Moritz R; Altmeyer P; Stücker M
    Vasa; 2012 Jul; 41(4):243-7. PubMed ID: 22825857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The French polidocanol study on long-term side effects: a survey covering 3,357 patient years.
    Guex JJ; Schliephake DE; Otto J; Mako S; Allaert FA
    Dermatol Surg; 2010 Jun; 36 Suppl 2():993-1003. PubMed ID: 20590706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indications for the sclerosing agent polidocanol (aetoxisclerol dexo, aethoxisklerol kreussler).
    Guex JJ
    J Dermatol Surg Oncol; 1993 Oct; 19(10):959-61. PubMed ID: 8408916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.